Date |
Title |
April 11, 2024, 3:44 pm |
Klopp's Plea for Patience Amidst Premier League Title Race |
April 11, 2024, 3:40 pm |
Avenir Revolutionizes Wealth Management with Pre-Seed Funding |
April 11, 2024, 3:40 pm |
Reshape Revolutionizes Lab Automation with $20M Series A Funding |
April 11, 2024, 3:40 pm |
Onum Revolutionizes Data Management with $28M Funding |
April 11, 2024, 3:40 pm |
Tomo Revolutionizes Social Media with Tomoji Launchpad and TomoID |
April 11, 2024, 3:40 pm |
Cyera: A Rising Star in Cybersecurity |
April 11, 2024, 3:40 pm |
Proxima Fusion: A Stellar Rise in the Nuclear Fusion Race |
April 11, 2024, 3:35 pm |
Guesty's $130 Million Funding Boost |
April 11, 2024, 3:35 pm |
FloQast's Financial Success Story |
April 11, 2024, 3:35 pm |
Waymap Revolutionizes Navigation with £7M Funding |
April 11, 2024, 3:35 pm |
Gilion: A Rising Star in European Funding |
April 11, 2024, 3:35 pm |
Mode Inc. Revolutionizes Industry with $8.75M in Funding |
April 11, 2024, 3:35 pm |
Platform Science Secures $125M in Funding |
April 11, 2024, 3:35 pm |
Adro Revolutionizes Banking for International Students |
April 11, 2024, 3:35 pm |
Revolutionizing Manufacturing with AI: Oden Technologies' $28.5M Series B Funding |
April 11, 2024, 3:35 pm |
Sapien's $5M Seed Funding Boost |
April 11, 2024, 3:35 pm |
ID5 Secures $20 Million in Series B Funding |
April 11, 2024, 3:35 pm |
Alethea Secures $20M in Series B Funding |
April 10, 2024, 9:30 am |
Piramal Alternatives Invests in Biodeal Pharmaceuticals |
April 10, 2024, 3:49 am |
Cancer Drugs: Promises vs. Reality |